Qianqian Lei, MD

Qianqian LEI

MD, Department of Radiation Oncology, Chongqing University Cancer Hospital

No. 181 Hanyu Road, Shapingba District, Chongqing 400030, China

Tel: +86 15310477257

Email: qianqian.lei@cqu.edu.cn

EDUCATION EXPERIENCE

West China Hospital, Sichuan University, Sichuan, China

1. 2011-2014, Doctor of Medicine in Oncology


2. 2004 -2011, Master’s degree in Oncology

PROFESSIONAL EMPLOYMENT

1. From 10/2019 to now and from 07/2014 to 10/2018, Chongqing University Cancer Hospital


2. From 11/2018 to 10/2019, Lucien Neuwirth Cancer Institute, Saint-Étienne, France

THE SCIENTIFIC RESEARCH PROJECTS

1. Chongqing Natural Science Foundation Project, cstc2019jcyj-msxmX0648, miR-221-3p improve the malignancy of triple negative breast cancer by targeting PARP1 and interacting with NF- ? B pathway, ¥50,000, completed, presided over


2. Chongqing Natural Science Foundation Project,CSTB2024NSCQ-MSX0629, Mechanism of PARP1/TCF7L2 axis mediated aerobic glycolysis in regulating the metastasis of triple negative breast cancer, ¥50,000, in research, presided over

PUBLICATION

1. Zhang X^#, Yan J^#, Lei QQ^#, et al., Int J Radiat Oncol Biol Phys. 2025, 121(4):980-990.


2. Lei QQ^#, Sui JD^#, Jin F, et al., Transl Cancer Res 2021, 10(7):3538-3547.


3. Liu J^#, Wu S, Xie X, Wang Z, Lei Q*, Technology and health care: official journal of the European Society for Engineering and Medicine 2020:1-9.


4. Liu J^#, Wu S, Xie X, Wang Z, Lei Q*, Hereditas 2020, 157(1):29.

CONFERENCE

1. 
   

   Qianqian Lei, Kegui Weng, Xian Zhou, Yanyan Long, Min Ying, Jing Chen, Ye Hong, Mechanism of miR-221-3p/PARP1 regulating the progression of triplenegative breast cancer through the NF-?B pathway, San Antonio Breast Cancer Symposium (SABCS) Annual Meeting 2024, Dec 2024, San Antonio, Texas, USA.

   
   

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none